×
Description of Lenvanix 10
: First new frontline treatment option for
HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the
pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of
differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular
Carcinoma (HCC).
Generic | Brand Name | Formulation & Strength | Pack Size |
---|---|---|---|
Lenvatinib | Lenvanix 10 | Capsule ( 10 mg ) | 30's Pot |
Website Prescribing Information Order Now
-
Fllow Us